ONGLYZA (Cardinal Health)
Welcome to the PulseAid listing for the ONGLYZA drug offered from Cardinal Health. This Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cardinal Health |
NON-PROPRIETARY NAME: | SAXAGLIPTIN |
SUBSTANCE NAME: | SAXAGLIPTIN HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitor [EPC],Dipeptidyl Peptidase 4 Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
ONGLYZA HUMAN PRESCRIPTION DRUG Details:
Item Description | ONGLYZA from Cardinal Health |
LABELER NAME: | Cardinal Health |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2009-07-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 55154-0611_aa15c4cd-ab38-488c-809a-e46256a53198 |
PRODUCT NDC: | 55154-0611 |
APPLICATION NUMBER: | NDA022350 |
Other SAXAGLIPTIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: